This Special Report provides clinical perspectives from the trenches on the diagnosis and management of eosinophilic esophagitis in the time of COVID-19, the challenges associated with identifying and caring for these patients, and the potential role of telemedicine in managing them through the pandemic and beyond.
Treatment with FMT is effective for preventing recurrent C. diff infection in adults with robust immune systems, for whom standard antibiotics do not eliminate the…
The FDA has approved Lutathera for certain pediatric patients with gastroenteropancreatic neuroendocrine tumors.
The combination of rectal indomethacin and a pancreatic stent is superior to rectal indomethacin alone in preventing pancreatitis after ERCP.
The FDA expanded indication for the subcutaneous administration of vedolizumab to certain patients with Crohn’s disease.
Adults newly diagnosed with active Crohn’s disease benefit from immediate treatment with advanced therapies, according to research.
Adults newly diagnosed with active Crohn’s disease benefit from immediate treatment with advanced therapies, according to research.
Hospitalized patients with IBD treated using a novel pain management protocol used less opioids in a recent study.
Some patients remained unaware of their microscopic colitis diagnosis and reported persistent symptoms one year after biopsies confirmed their disease.
The FDA has granted 510(k) clearance to a new artificial intelligence program (CAD EYE, Fujifilm) to aid in detection of polyps during endoscopy.
Over the past few decades, the demographics, location and stage of colorectal cancer at diagnosis have shifted, resulting in new patterns of CRC.
